Albireo Sells Priority Review Voucher (PRV) for $105 Million

NEXT STORY
INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021
PREV STORY
New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Advantages of Using the Guardant360® Liquid Biopsy Blood Test for Comprehensive Genomic Profiling in Advanced Lung Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ElsaLys Biotech announces submission of Biologics License Application to FDA for LEUKOTAC® (inolimomab) for the treatment of graft-versus-host disease in adult patients

author_avatar
NASDAQ Market News

Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice

author_avatar
NASDAQ Market News

Peptide Therapeutics Market Will Reach USD 43.26 Billion By 2024, Globally: Zion Market Research

According to the report, global peptide therapeutics market was valued at approximately USD 23.05 ...

author_avatar
NASDAQ Market News